Melatonin
Circadin, Melatonin Neurim, Slenyto · ATC code N05CH01
Also known as: Melatonina, Mélatonine · Brand names: Circadin, Melatonin Neurim, Slenyto, Evoqi, Melatal, Mellozzan, Melozostrin, Pinealin, Voquily, Abdi İbrahim Melatonin, Baymela, Circaday, Cozymel, İlko Melatonin, Insovef …
- Key facts
- Active substance
- Melatonin
- Drug class
- Melatonin receptor agonist
- ATC code
- N05CH01
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Circadin 2 mg prolonged-release tablets · Melatonin Neurim 2 mg prolonged-release tablets · Slenyto 1 mg prolonged-release tablets / Slenyto 5 mg prolonged-release tablets
- Marketing authorisation holder
- RAD Neurim Pharmaceuticals EEC SARL
- Information as of
- 2026-11-03
Key facts
Melatonin is the pineal sleep hormone. This page covers the EU prolonged-release tablets: Circadin and Melatonin Neurim (2 mg) for primary insomnia in patients aged 55 or over, and Slenyto (1 mg and 5 mg) for insomnia in children and adolescents with autism spectrum disorder, neurogenetic disorders or ADHD.
What it is used for
- Circadin, Melatonin Neurim: short-term monotherapy of primary insomnia with poor quality of sleep in patients aged 55 or over
- Slenyto: insomnia in children and adolescents aged 2-18 years with autism spectrum disorder and/or neurogenetic disorders (e.g. aberrant melatonin secretion, nocturnal awakenings) when sleep hygiene has been insufficient
- Slenyto: insomnia in children and adolescents aged 6-17 years with ADHD when sleep hygiene has been insufficient
Dosing
- Circadin, Melatonin Neurim: 2 mg once daily, 1-2 hours before bedtime and after food, for up to thirteen weeks
- Slenyto (ASD/neurogenetic disorders): start 2 mg, increase to 5 mg if response is inadequate, maximum 10 mg
- Slenyto (ADHD): start 1-2 mg, adjustable to 5 mg per day, maximum 10 mg if clinically needed
- Slenyto once daily 0.5-1 hour before bedtime with or after food; evaluate effect after about 3 months and review at least every 6 months
- Swallow tablets whole (Slenyto may be put into food such as yoghurt); not recommended in hepatic impairment; caution in renal impairment
Contraindications
- Hypersensitivity to melatonin or any excipient
Important warnings
- Drowsiness and daytime fatigue; caution where drowsiness is a safety risk (e.g. driving); in ADHD may worsen daytime inattention or behaviour
- Not recommended in autoimmune diseases (no clinical data)
- Contains lactose: not for patients with hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption
Side effects
- Adults (Circadin): headache, nasopharyngitis, back pain and arthralgia were most common, at rates similar to placebo
- Uncommon in adults: irritability, nervousness, restlessness, abnormal dreams, migraine, dizziness, somnolence, hypertension, abdominal pain, rash
- Children (Slenyto): somnolence, fatigue, hangover, mood swings, irritability, aggression, headache, sudden onset of sleep, sinusitis
Interactions
- Fluvoxamine raises melatonin levels (17-fold higher AUC) via CYP1A2 and CYP2C19 inhibition: avoid
- Alcohol reduces the effect; benzodiazepines and Z-hypnotics (zaleplon, zolpidem, zopiclone) have enhanced sedation
- CYP1A2 inhibitors (quinolones, cimetidine), oestrogens and methoxypsoralen increase melatonin; carbamazepine, rifampicin and smoking reduce it
- Slenyto: NSAIDs in the evening and beta-blockers may suppress endogenous melatonin
Pregnancy and breastfeeding
- No clinical data in pregnancy; use not recommended (Circadin) or preferably avoided (Slenyto)
- Probably passes into breast milk; breast-feeding not recommended during treatment with Circadin; with Slenyto weigh breast-feeding against therapy
Summary of the official product information, written with AI on 2026-11-03. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- CircadinRAD Neurim Pharmaceuticals EEC SARL · EMEA/H/C/000695
- Melatonin NeurimRAD Neurim Pharmaceuticals EEC SARL · EMEA/H/C/005603
- SlenytoRAD Neurim Pharmaceuticals EEC SARL · EMEA/H/C/004425
Source: European Medicines Agency (EMA), product information
Germany
- EvoqiMedice Arzneimittel Pütter Gmbh & Co. Kg · 1 register entry
- MelatalVitabalans Oy · 1 register entry
- MelatoninMedice Arzneimittel Pütter Gmbh & Co. Kg, Fairmed Healthcare Gmbh, Unimedic Pharma Ab, Neuraxpharm Arzneimittel Gmbh, Pharma Nord Aps (Vojens), Ratiopharm Gmbh, Vitabalans Oy, Bluefish Pharmaceuticals Ab, Orifarm Generics A/S, Aspire Pharma (Malta) Limited, Przedsiębiorstwo Farmaceutyczne Lek-Am Sp. Zo.O., Puren Pharma Gmbh & Co. Kg, Stadapharm Gmbh, Aliud Pharma Gmbh · 14 register entries
- MellozzanMedice Arzneimittel Pütter Gmbh & Co. Kg · 1 register entry
- MelozostrinFairmed Healthcare Gmbh · 1 register entry
- PinealinAgb-Pharma Ab · 2 register entries
- VoquilyRad Neurim Pharmaceuticals Eec Sarl · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03
Austria
- MelatoninMedice Arzneimittel Pütter Gmbh & Co. Kg, Bluefish Pharmaceuticals Ab · 2 register entries
- MellozzanMedice Arzneimittel Pütter Gmbh & Co. Kg · 1 register entry
- MelozostrinFairmed Healthcare Gmbh · 1 register entry
- PinealinAgb-Pharma Ab · 1 register entry
- VoquilyRad Neurim Pharmaceuticals Eec Sarl · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03
Turkey
- Abdi İbrahim MelatoninABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- BaymelaEMPHARMA İLAÇ LTD. ŞTİ. · 1 register entry
- CircadayORZAKS İLAÇ VE KİMYA SAN TİC. A.Ş. · 1 register entry
- CozymelBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- İlko MelatoninİLKO İLAÇ SAN.VE TİC. A.Ş. · 1 register entry
- InsovefVEFA İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- MelabiemBİEM İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- MelaforALİ RAİF İLAÇ SAN. A.Ş. · 1 register entry
- MellarestDEVA HOLDİNG A.Ş. · 1 register entry
- MelogenGENSU PHARMA İLAÇ SAN VE TİC LTD ŞTİ · 1 register entry
- MelonisenkARGİS İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- MihadaHADA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 1 register entry
Show all 14 brand names
- Tab MelatoninTAB İLAÇ SAN. A.Ş. · 1 register entry
- Vefarma MelatoninVEFARMA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-03
Brand names in 25 more European countries
- Belgium
- Melatonin Ab, Melatonin Ace Pharmaceuticals, Melatonin Orifarm, Melatonin Orion, Melatonin Unimedic Pharma, Melatonine Pharma Nord, Melatonine Viatris, Noxarem, Pinealin, Voquily
- Cyprus
- Melatonin Medicair
- Czechia
- Melatonin Orion, Melatonin Vitabalans
- Denmark
- Adaflex, Mecastrin, Melatal, Melatonin, Mellozzan, Melozostrin, Orimelan, Senaxa
- Estonia
- Melatonin Orion, Melatonin Pharma Nord, Melatonin Vitabalans
- Finland
- Ceyesta, Dagravit, Mecastrin, Melatonin, Mellozzan, Noxarem, Orimelan, Roter, Senaxa, Vemedia
- France
- Adaflex, Aphelys, Melatonine Bluefish, Melatonine Lp Arrow, Melatonine Lp Venipharm, Melatonine Viatris Lp, Melatonine Zentiva Lp, Noxarem, Voquily
- Greece
- Medynote, Melatonin Medicair, Nidymo
- Hungary
- Bio-Melatonin Pharmyn, Melatonin Orion, Melatonin Pharma Nord, Melatonin-Valerosolv Teva Gyógyszergyár, Melatonin Vitabalans, Voquily
- Iceland
- Circadin, Lestinora, Melatonin Bluefish, Melatonin Evolan, Melatonin Medice, Melatonin Neurim, Melatonin Teva, Melatonin Viatris, Melatonin Vitabalans, Pinealin, Slenyto
- Ireland
- Calasu, Meladura, Melatonin Pharma Nord, Melnite, Voquily
- Italy
- Baldinas, Eusom, Melatonina Adoh, Melatonina Aurobindo, Melatonina Doc, Melatonina Noxarem, Melatonina Viatris, Melatonina Zentiva, Mellozzan, Sloremina, Syncropine, Voquily, Yayoi
- Latvia
- Melatonin Orion Pharma, Melatonin Pharma Nord, Melatonin Vitabalans
- Liechtenstein
- Circadin, Melatonin Neurim, Slenyto
- Lithuania
- Melatonin Orion, Melatonin Vitabalans, Melatoninas Pharma Nord
- Luxembourg
- Melatonin Pharma Nord, Melatonine Pharma Nord, Melatonine Viatris, Noxarem, Pinealin
- Malta
- Melatonin Senaxa
- Netherlands
- Davitamon, Kruidvat, Melatonine, Shiepz, Trekpleister, Valdispert, Voquily
- Norway
- Circadin, Mallozen, Melatal, Melatonin Ace Pharmaceuticals, Melatonin Agb, Melatonin Aspire, Melatonin Bluefish, Melatonin Glenmark, Melatonin Neurim, Melatonin Newbury, Melatonin Orifarm, Melatonin Orion Pharma, Melatonin Pharma Nord, Melatonin Teva, Melatonin Unimedic Pharma, Melatonin Viatris, Orimelan, Pinealin, Senaxa, Slenyto
- Poland
- Melabiorytm, Melanoc Pr, Melasolaren, Melatonin Orion, Melatonin Vitabalans, Melatonina Lek-Am, Melatonina Noctis, Melatonina Olimp, Melatonina Pharma Nord, Melatonina Polfarmex, Melatonina Polski Lek, Meldream Pr, Senaxa Pr, Sental, Voquily
- Portugal
- Adaflex, Melatonina Alter, Melatonina Bluefish, Melatonina Generis, Melatonina Mylan, Melatonina Noxarem, Melatonina Pharma Nord, Melatonina Teva
- Slovakia
- Melatonin Vitabalans
- Slovenia
- Melatonin
- Spain
- Conciliax, Melatonina Aristo, Melatonina Aurovitas, Melatonina Bluefish, Melatonina Cinfa, Melatonina Fairmed, Melatonina Perrigo, Melatonite, Noxarem, Senaxa, Voquily
- Sweden
- Aritonin, Mecastrin, Meladura, Melatan, Melatonin, Mellaras, Mellozzan, Melozostrin, Orimelan, Pinealin, Senaxa, Voquily
EMA – Article 57 product data (EU/EEA), 2026-11-03
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Circadin – EPAR, Product Information. 2026-11-03. https://www.ema.europa.eu/en/documents/product-information/circadin-epar-product-information_en.pdf
- European Medicines Agency. Melatonin Neurim – EPAR, Product Information. 2026-11-03. https://www.ema.europa.eu/en/documents/product-information/melatonin-neurim-epar-product-information_en.pdf
- European Medicines Agency. Slenyto – EPAR, Product Information. 2026-11-03. https://www.ema.europa.eu/en/documents/product-information/slenyto-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-03. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC N05CH.
Editorial: Medelix editorial team · last updated 2026-11-03 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.